The ACORD collaboration: Innovative Clinical Trials for Neurodegenerative Diseases

ACORD is a pioneering collaboration that brings together experts from a wide range of disciplines to accelerate the development of treatments for neurodegenerative diseases. In this episode, we explore how ACORD works in practice, the innovative methodologies that underpin it, including the multi-arm, multi-stage trial design, and the opportunities it creates for researchers at different stages of their careers. We speak with James Carpenter, one of ACORD’s founders, and Ed Jabbari, an ACORD Fellow, about the vision behind the collaboration, its potential to transform clinical research in neurodegenerative diseases, and how it has shaped Ed’s career journey.

Further information is available on the ACORD collaboration page at www.innovative-ctu.ucl.ac.uk/.